Next-level insights for next-level care Renasight™ is a comprehensive 380+ gene panel for patients with chronic kidney disease (CKD), electrolyte disorders, hypertension, and nephrolithiasis to determine if there is a genetic cause for their kidney disease or an increased hereditary risk due to family history. By leveraging next-generation sequencing (NGS) and other methodologies, Renasight identifies autosomal dominant, autosomal recessive, and X-linked disorders with a ≥ 99% detection rate across genes screened. Renasight is: - Comprehensive: Analyzes over 380 genes to provide clinically relevant information - Convenient: Remote testing services for providers and patients - Accessible: Affordable with limited to no patient responsibility for most patients Learn more or get started today at natera.com/renasight